Skip to main content

Katerzia Prices, Coupons and Patient Assistance Programs

Katerzia (amlodipine) is a member of the calcium channel blockers drug class and is commonly used for Angina, Coronary Artery Disease, and High Blood Pressure.

The cost for Katerzia oral suspension (1 mg/mL) is around $628 for a supply of 150 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Katerzia is available as a brand name drug only, a generic version is not yet available. View generic Katerzia availability for more details.

Katerzia prices

Oral Suspension

Quantity Per unit Price
150 milliliters $4.18 $627.56

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Katerzia Coupons, Copay Cards and Rebates

Katerzia offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Katerzia eVoucherRx Program

Eligible commercially insured patients may pay no more $30 per prescription at a participating pharmacy; for additional information contact the program at 844-472-2032.

Applies to:
Katerzia
Number of uses:
Per prescription until program expires

Form more information phone: 844-472-2032 or Visit website

Katerzia Bridge Drug Program

Eligible commercially insured patients experiencing an insurance delay longer than 48 hours may be able to receive up to 30 days of medication at no cost; for additional information contact the program at 844-472-2032.

Applies to:
Katerzia
Number of uses:
Temporary Assistance

Form more information phone: 844-472-2032 or Visit website

Patient Assistance & Copay Programs for Katerzia

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Katerzia (amlodipine benzoate) Oral Suspension

More information please phone: 866-316-7263 Visit Website

Provider: Azurity Solutions: Katerzia

Eligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Medically Necessary as determined by a Doctor
  4. Must be treated by US licensed healthcare provider
  5. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Katerzia (amlodipine benzoate) Oral Suspension

More information please phone: 844-472-2032 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.